v3.26.1
Award Timing Disclosure
12 Months Ended
Jan. 03, 2026
Mar. 21, 2025
USD ($)
$ / shares
Jan. 08, 2025
USD ($)
$ / shares
Award Timing Disclosures [Line Items]      
Award Timing MNPI Disclosure
Equity Grant Practices
The Compensation Committee generally grants options annually to executives at its first scheduled meeting of the applicable fiscal year. Throughout the year, option awards may be made to new hires or in connection with promotions or other changes in employment. The Compensation Committee does not grant equity-based awards in anticipation of the release of material nonpublic information and does not time the disclosure of material nonpublic information for purposes of affecting the value of executive compensation.
The following table contains information required by Item 402(x)(2) of Regulation
S-K
about options granted to the Company’s named executive officers in 2025 during the period beginning four business days prior to and ending one business day following the filing of a periodic report on Form
10-Q
or Form
10-K,
or the filing or furnishing of a Form
8-K
that discloses material nonpublic information.
 
Name
  
Grant date
    
Number of
securities
underlying
the award
    
Exercise
price of the
award
($/Sh)
    
Grant date
fair value
of the
award ($)
    
Percentage change
in the closing
market price of the
securities
underlying the
award between the
trading day ending
immediately prior
to the disclosure of
material nonpublic
information and the
trading day
beginning
immediately
following the
disclosure of
material nonpublic
information
 
Christopher Morris
    

1/8/2025
(1)

1/8/2025
(1)

1/8/2025
(1)
 
 
 
    

425,000
425,000
800,000
 
 
 
    

12.00
9.00
6.41
 
 
 
    

1,615,000
1,725,500
3,504,000
 
 
 
    
2.11
2.11
2.11

Katie Mullen
    

3/21/2025
(2)

3/21/2025
(2)

3/21/2025
(2)
 
 
 
    

180,000
180,000
220,000
 
 
 
    

12.00
9.00
3.99
 
 
 
    

370,800
399,600
594,000
 
 
 
    
6.23
6.23
6.23

 
(1)
Our Current Report on Form
8-K
disclosing a press release including certain commentary regarding the fiscal year ended January 4, 2025 was filed on January 13, 2025.
(2)
Our Current Report on Form
8-K
disclosing the approval of the Inducement Plan was filed on March 21, 2025.
   
Award Timing Method The Compensation Committee generally grants options annually to executives at its first scheduled meeting of the applicable fiscal year.    
Award Timing MNPI Considered false    
Award Timing, How MNPI Considered The Compensation Committee generally grants options annually to executives at its first scheduled meeting of the applicable fiscal year. Throughout the year, option awards may be made to new hires or in connection with promotions or other changes in employment. The Compensation Committee does not grant equity-based awards in anticipation of the release of material nonpublic information and does not time the disclosure of material nonpublic information for purposes of affecting the value of executive compensation.    
MNPI Disclosure Timed for Compensation Value false    
Awards Close in Time to MNPI Disclosures, Table
The following table contains information required by Item 402(x)(2) of Regulation
S-K
about options granted to the Company’s named executive officers in 2025 during the period beginning four business days prior to and ending one business day following the filing of a periodic report on Form
10-Q
or Form
10-K,
or the filing or furnishing of a Form
8-K
that discloses material nonpublic information.
 
Name
  
Grant date
    
Number of
securities
underlying
the award
    
Exercise
price of the
award
($/Sh)
    
Grant date
fair value
of the
award ($)
    
Percentage change
in the closing
market price of the
securities
underlying the
award between the
trading day ending
immediately prior
to the disclosure of
material nonpublic
information and the
trading day
beginning
immediately
following the
disclosure of
material nonpublic
information
 
Christopher Morris
    

1/8/2025
(1)

1/8/2025
(1)

1/8/2025
(1)
 
 
 
    

425,000
425,000
800,000
 
 
 
    

12.00
9.00
6.41
 
 
 
    

1,615,000
1,725,500
3,504,000
 
 
 
    
2.11
2.11
2.11

Katie Mullen
    

3/21/2025
(2)

3/21/2025
(2)

3/21/2025
(2)
 
 
 
    

180,000
180,000
220,000
 
 
 
    

12.00
9.00
3.99
 
 
 
    

370,800
399,600
594,000
 
 
 
    
6.23
6.23
6.23

 
(1)
Our Current Report on Form
8-K
disclosing a press release including certain commentary regarding the fiscal year ended January 4, 2025 was filed on January 13, 2025.
(2)
Our Current Report on Form
8-K
disclosing the approval of the Inducement Plan was filed on March 21, 2025.
   
Christopher Morris Grant Date One [Member]      
Awards Close in Time to MNPI Disclosures      
Name     Christopher Morris
Underlying Securities     425,000
Exercise Price | $ / shares     $ 12
Fair Value as of Grant Date | $     $ 1,615,000
Underlying Security Market Price Change     2.11
Christopher Morris Grant Date Two [Member]      
Awards Close in Time to MNPI Disclosures      
Underlying Securities     425,000
Exercise Price | $ / shares     $ 9
Fair Value as of Grant Date | $     $ 1,725,500
Underlying Security Market Price Change     2.11
Christopher Morris Grant Date Three [Member]      
Awards Close in Time to MNPI Disclosures      
Underlying Securities     800,000
Exercise Price | $ / shares     $ 6.41
Fair Value as of Grant Date | $     $ 3,504,000
Underlying Security Market Price Change     2.11
Katie Mullen Grant Date One [Member]      
Awards Close in Time to MNPI Disclosures      
Name   Katie Mullen  
Underlying Securities   180,000  
Exercise Price | $ / shares   $ 12  
Fair Value as of Grant Date | $   $ 370,800  
Underlying Security Market Price Change   6.23  
Katie Mullen Grant Date Two [Member]      
Awards Close in Time to MNPI Disclosures      
Underlying Securities   180,000  
Exercise Price | $ / shares   $ 9  
Fair Value as of Grant Date | $   $ 399,600  
Underlying Security Market Price Change   6.23  
Katie Mullen Grant Date Three [Member]      
Awards Close in Time to MNPI Disclosures      
Underlying Securities   220,000  
Exercise Price | $ / shares   $ 3.99  
Fair Value as of Grant Date | $   $ 594,000  
Underlying Security Market Price Change   6.23